'Really reassuring': Israeli study on COVID-19 vaccine finds low risk of reaction among those with history of allergies
About 98 per cent of people with a history of multiple allergies suffered no allergic reactions after receiving a Pfizer-BioNTech vaccine, according to a study conducted in Israel and published recently online in JAMA Network Open.
Of the approximately 2 per cent who did react, none required hospitalization, and symptoms cleared up with medication within a few hours.
“That's really reassuring,” said Dr. Donald Vinh, an immunologist at the MUHC, who explained the study is important because it replicates previous but smaller studies with similar results.
Another point highlighted by the study is that “even if you had a reaction to the first dose of your Pfizer vaccine, you can still go ahead and proceed with your second dose with essentially no risk of having a recurrence of that same allergic reaction,” Vinh said in an interview with CTV News, after reviewing the publication.
Vinh said this brings to the forefront what most studies have shown, “which is concern about allergies should not be a reason to avoid getting the COVID vaccines.”
SAFEGUARDS IN PLACE
To reinforce that advice, Vinh offered encouragement to those with allergies who have held off getting a vaccine thus far, adding vaccines are administered in supervised settings in Quebec.
“They have the trained personnel, the equipment, and the necessary emergency medications in case there's an allergic reaction,” Vinh said.
People are pre-screened for allergies and any contraindications before receiving the shots and are monitored for at least 15 minutes afterward.
Even a serious reaction like anaphylaxis can be treated on the spot, he says.
The Israeli study had a similar framework in place but monitored individuals deemed to be at high risk for two hours following the injections.
The authors concluded that “only patients defined as highly allergic should receive vaccination under medical supervision.”
It’s not known how many Quebecers are shying away from vaccination because of fears related to allergies to food, medications, or environmental factors.
Vinh said it doesn’t appear to be an overwhelming number of people, but is a sizable proportion nonetheless, who should be “reassured,” by this research, and get vaccinated.
ALLERGY FEARS PRESENT AN OBSTACLE
Questions about allergy risks prompted the Sheba Medical Centre in Israel to open a COVID-19 referral centre when the country first rolled out its Pfizer-BioNTech vaccination campaign eight months ago.
“Concerns regarding safety and, particularly, severe allergic reactions to this vaccine are a significant obstacle to implementation of this large immunization program,” the study's authors wrote.
Between December 2020 to February 2021, researchers assessed 8,102 participants for allergy risks according to certain criteria.
There were 429 individuals in the group considered to be at high risk for allergic reactions, which amounted to 5 per cent of the total number of participants.
Women made up the majority of the high-risk group (70.9 per cent), with 63.2 per cent of the entire group reporting prior anaphylaxis.
Following immunization with the first dose, nine women had allergic reactions within the two-hour observation period.
Six of them had minor reactions including skin flushing, tongue or uvula swelling, or a cough that diminished after treatment with an antihistamine.
Three women had anaphylactic reactions 10 to 20 minutes after getting the shot, among other symptoms.
They were treated with several medications including adrenaline and antihistamines. The symptoms resolved with 2 to 6 hours and no one required hospitalization.
When it came time for the second dose, four patients from the highly allergic group had mild allergic reactions.
CTVNews.ca Top Stories
B.C. seeks ban on public drug use, dialing back decriminalization
The B.C. NDP has asked the federal government to recriminalize public drug use, marking a major shift in the province's approach to addressing the deadly overdose crisis.
More than 115 cases of eye damage reported in Ontario after solar eclipse
More than 115 people who viewed the solar eclipse in Ontario earlier this month experienced eye damage after the event, according to eye doctors in the province.
Orca calf that was trapped in B.C. lagoon for weeks swims free
An orca whale calf that has been stranded in a B.C. lagoon for weeks after her pregnant mother died swam out on her own early Friday morning.
Last letters of pioneering climber who died on Everest reveal dark side of mountaineering
George Mallory is renowned for being one of the first British mountaineers to attempt to scale the dizzying heights of Mount Everest during the 1920s. Nearly a century later, newly digitized letters shed light on Mallory’s hopes and fears about ascending Everest.
Sophie Gregoire Trudeau on navigating post-political life, co-parenting and freedom
Sophie Gregoire Trudeau says there is 'still so much love' between her and Prime Minister Justin Trudeau, as they navigate their post-separation relationship co-parenting their three children.
'I was scared': Ontario man's car repossessed after missing two repair loan payments
An Ontario man who took out a loan to pay for auto repairs said his car was repossessed after he missed two payments.
Trump's lawyers try to discredit testimony of prosecution's first witness in hush money trial
Donald Trump's defence team attacked the credibility Friday of the prosecution's first witness in his hush money case, seeking to discredit testimony detailing a scheme between Trump and a tabloid to bury negative stories to protect the Republican's 2016 presidential campaign.
U.S. flight attendant indicted in attempt to record teen girl in airplane bathroom
An American Airlines flight attendant was indicted Thursday after authorities said he tried to secretly record video of a 14-year-old girl using an airplane bathroom last September.
Powerful tornado tears across Nebraska, weather service warns of 'catastrophic' damage
Devastating tornadoes tore across parts of eastern Nebraska and northeast Texas Friday as a multi-day severe thunderstorm event ramped up in the central United States.